What screenings are most appropriate for a 23-year-old cisgender female with HIV (Human Immunodeficiency Virus) on Antiretroviral Therapy (ART) with a stable CD4 (Cluster of Differentiation 4) count and undetectable HIV RNA, who reports two new sexual partners since her last clinic visit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Screening Recommendations for HIV-Positive Patient with New Sexual Partners

This patient should receive gonorrhea/chlamydia testing at each site of reported intercourse and syphilis screening (Answer A).

Rationale for Site-Specific STI Screening

This 23-year-old woman with well-controlled HIV and two new sexual partners meets clear criteria for comprehensive STI screening based on multiple risk factors:

  • Age-based risk: She is under 25 years old and sexually active, which automatically qualifies her for chlamydia and gonorrhea screening regardless of HIV status 1

  • Multiple partners as a risk factor: The presence of multiple new partners since her last visit is specifically identified as a risk factor that should prompt repeated STI screening 1

  • Site-specific testing is essential: Guidelines explicitly recommend testing at each site of reported intercourse (vaginal, rectal, and pharyngeal if applicable) because infections can be anatomically isolated and asymptomatic 1

Required Screening Components

Gonorrhea and Chlamydia Testing

  • Vaginal swab (preferred method for women) or cervical swab with NAAT 1
  • Rectal NAAT if receptive anal sex is reported 1
  • Pharyngeal NAAT if receptive oral sex is reported 1

Syphilis Screening

  • Serologic testing is recommended for all sexually active HIV-infected persons at least annually 1, 2
  • Given new partners, this patient warrants syphilis screening at this visit 1
  • Both nontreponemal (RPR or VDRL) and treponemal tests (EIA or CIA) should be performed 1

Why Other Options Are Incorrect

Option B (HBV serologies and syphilis): While syphilis is appropriate, HBV serologies should have been performed at initial HIV diagnosis, not routinely at follow-up visits with new partners 3

Option C (Gonorrhea/chlamydia and Pap smear): Although both are important, Pap smear timing is not dictated by new sexual partners but rather by cervical cancer screening intervals for HIV-positive women 3

Option D (HBV and HCV serologies): These are baseline or risk-specific screenings (particularly HCV for injection drug users), not routine screenings triggered by new sexual partners 3

Screening Frequency Considerations

For HIV-infected individuals with ongoing risk behaviors:

  • More frequent screening (every 3-6 months) is appropriate for patients with multiple partners, as this patient demonstrates 1, 2
  • The presence of new partners indicates she should be on an accelerated screening schedule rather than annual screening 1
  • If any STI is detected, rescreening should occur 3 months after treatment to detect reinfection 4

Critical Clinical Pearls

Common pitfall: Failing to screen all anatomic sites of exposure leads to missed infections, as many STIs are asymptomatic and site-specific 1

Prevention counseling: This visit should also include discussion of condom use, partner notification, and the increased risk of HIV transmission when STIs are present 3

Documentation: Note that continued risk behavior warrants more frequent STI screening at future visits 3

Related Questions

What are the standard procedures and ICD-10 (International Classification of Diseases, 10th Revision) codes for a patient undergoing a sexually transmitted disease (STD) check, including tests for chlamydia, gonorrhea, syphilis, and Human Immunodeficiency Virus (HIV)?
What tests should be ordered for a comprehensive sexually transmitted infection (STI) screen?
Can reliable STI screening be performed during a patient's menstrual period?
Which screening tests should be performed for sexually transmitted infections in sexually active adults?
What is the recommended frequency for routine testing for sexually transmitted infections (STIs)?
What is the best recommendation for pneumococcal vaccination in a patient with Human Immunodeficiency Virus (HIV) who received one dose of pneumococcal conjugate vaccine (PCV20) one year prior?
What is the recommended anticoagulant regimen, including Aspirin (ASA), for patients undergoing hip total replacement at high risk of Venous Thromboembolism (VTE)?
What is the best course of action for a patient with HIV (Human Immunodeficiency Virus) and G6PD (Glucose-6-Phosphate Dehydrogenase) deficiency who develops a pruritic maculopapular rash while taking sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis?
Will impetigo (a bacterial skin infection) resolve on its own without treatment?
What causes orange fingertips and how is it treated?
What is the workup and replacement dose for a patient with metabolic acidosis and a decreased bicarbonate (HCO3) level of 16 mEq/L?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.